Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
J Clin Invest 2008
The Danish pharma company announced this morning that it will roll out what its calling the first multimonth subscription program for an FDA-approved obesity drug, offering Wegovy at a fixed monthly price that features savings of up to $1,200 a year for self-pay patients
The established treatment for the resulting hypothyroidism is thyroid hormone replacement, usually levothyroxine, which replaces the hormone the thyroid can no longer make in sufficient amounts
The generic drug also must be therapeutically equivalent
The pills also have the potential to lower costs, which would allow for more equitable access, says Stanford
I may never know
US$ 24.11
US$ 21.39
US$ 23.97
US$ 20.84
US$ 21.39
US$ 24.91
US$ 29.60
US$ 21.75
US$ 20.15
